TOBAM - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 127 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
TOBAM ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q2 2020$1,296,000
+45.9%
46,979
-5.5%
0.08%
+18.6%
Q1 2020$888,000
-10.3%
49,727
+25.9%
0.07%
+14.8%
Q4 2019$990,000
+18.4%
39,502
-15.7%
0.06%
+13.0%
Q3 2019$836,000
+14.7%
46,853
+41.5%
0.05%
+31.7%
Q2 2019$729,000
-41.7%
33,121
-19.0%
0.04%
-34.9%
Q1 2019$1,251,000
+122.2%
40,901
+67.7%
0.06%
+133.3%
Q4 2018$563,00024,3850.03%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,684,118$84,523,00016.48%
Cederberg Capital Ltd 3,400,000$108,868,0002.00%
Capital International Sarl 570,500$18,267,0001.91%
AIA Group Ltd 437,118$14,971,0001.72%
Capital International, Inc./CA/ 4,711,405$150,859,0001.40%
M&G INVESTMENT MANAGEMENT LTD 3,096,345$99,083,0000.62%
Bellevue Group AG 947,674$30,345,0000.35%
Sands Capital Management 7,051,916$225,802,0000.22%
E Fund Management (Hong Kong) Co., Ltd. 18,836$603,0000.21%
Hudson Bay Capital Management LP 1,031,212$33,020,0000.18%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders